Study describes the use of engineered commensal bacteria to increase antitumor immunity.
Opinion | Are GLP-1 Drug Holidays a Risk Worth Taking?
In part three of this three-part Instagram Live discussion, MedPage Today editor-in-chief Jeremy Faust, MD, Karl Nadolsky, DO, and Fatima Cody Stanford, MD, MPH, MPA,